Stock RVV REVIVE THERAPEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts Revive Therapeutics Ltd.

Equities

RVV

CA7615161030

Delayed Canadian Securities Exchange
Other stock markets
 03:06:49 2024-05-03 pm EDT 		5-day change 1st Jan Change
0.03 CAD +20.00% Intraday chart for Revive Therapeutics Ltd. 0.00% 0.00%
Apr. 23 FDA Grants Revive Therapeutics Type C Meeting Request For Bucillamine Study to Treat Long COVID MT
Apr. 23 Revive Therapeutics Brief: Announcing Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID MT

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RVV Stock
  4. News Revive Therapeutics Ltd.
  5. Transcripts